Allspring Global Investments Holdings, LLC Blueprint Medicines Corp Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 3,222 shares of BPMC stock, worth $268,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,222
Previous 3,206
0.5%
Holding current value
$268,747
Previous $296,000
5.07%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BPMC
# of Institutions
384Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$565 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$554 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$474 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$209 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$162 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $4.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...